Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Aier Eye Hospital Group (300015 CH)
Watchlist
141
Analysis
Health Care
•
China
Aier Eye Hospital Group Co., Ltd provides ophthalmological services. The Company's services include ophthalmological diagnosis and treatments.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
ZOZO Inc
•
10 Mar 2024 05:50
Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, A50, STTF, LowVol30, Value Up
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
1.1k Views
Share
bullish
•
Shaanxi Coal Industry
•
04 Mar 2024 06:30
China A50 ETF Rebalance: Four Changes in March
There are 4 changes for the China A50 ETFs at the close 15 March. There are flows on some stocks from other ETFs as well adding to impact. The adds...
Brian Freitas
Follow
544 Views
Share
bullish
•
Hygon Information Technology C
•
25 Feb 2024 05:50
Index Rebalance & ETF Flow Recap: HSCEI, HSCI, HSTECH, HSIII, STTF, Top50, Div+, FXI, FnGuide
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
1.1k Views
Share
bullish
•
Hygon Information Technology C
•
20 Feb 2024 06:30
Offshore China ETFs Rebalance Preview: Big Price Moves Could Lead to Four Changes
There could be 4 changes for the 2822/2823 ETFs in March and passive trackers will need to trade 0.16-0.79 days of ADV on the stocks. Some stocks...
Brian Freitas
Follow
504 Views
Share
bullish
•
Gushengtang
•
22 Jan 2024 08:55
Gushengtang (2273.HK) - Some New Business Updates and Positive Performance Forecasts
In addition to higher-than-expected 2023 results, strong growth would continue in 2024 and the next 5-10 years.Gushengtang's active share...
Xinyao (Criss) Wang
Follow
652 Views
Share
First
Previous
10
11
12
13
14
15
16
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x